Use this summary report to properly interpret 2019 NSDUH estimates of substance use and mental health issues. The report accompanies theannual detailed tablesand covers overall methodology, key definitions for measures and terms used in 2019 NSDUH reports and tables, and selected analyses of the measures and how they should be interpreted.The report is organized into five chapters:Introduction.Description of the survey, including information about the sample design, data collection procedures, and key aspects of data processing such as development of the analysis weights.Technical details on the statistical methods and measurement, such as suppression criteria for unreliable estimates, statistical testing procedures, issues around data accuracy, and measurement issues for selected substance use and mental health measures.Special topics related to prescription psychotherapeutic drugs.A comparison between NSDUH and other sources of data on substance use and mental health issues, including data sources for populations outside the NSDUH target population.An appendix covers key definitions used in NSDUH reports and tables.

Use this summary report to properly interpret 2022 NSDUH estimates related to substance use, mental health, and treatment. The report accompanies theannual detailed tablesand covers overall methodology, key definitions for measures and terms used in 2022 NSDUH reports and tables, and selected analyses of the measures and how they should be interpreted.The report is organized into five chapters:Introduction.Description of the survey, including information about the sample design, data collection procedures and questionnaire changes, and key aspects of data processing such as development of the analysis weights.Technical details on the statistical methods and measurement, such as suppression criteria for unreliable estimates, statistical testing procedures, revised estimates for 2021 to account for data collection mode, and issues around selected substance use and mental health measures.Special topics related to prescription psychotherapeutic drugs.Description of other sources of data on substance use and mental health issues in the United States, including data sources for populations outside the NSDUH target population.An appendix covers key definitions used in NSDUH reports and tables.

Use this summary report to properly interpret 2020 NSDUH estimates of substance use and mental health issues. The report accompanies theannual detailed tablesand covers overall methodology, key definitions for measures and terms used in 2020 NSDUH reports and tables, and selected analyses of the measures and how they should be interpreted.The report is organized into six chapters:Introduction.Description of the survey, including information about the sample design, data collection procedures, and key aspects of data processing such as development of the analysis weights.Technical details on the statistical methods and measurement, such as suppression criteria for unreliable estimates, statistical testing procedures, issues around data accuracy, and measurement issues for selected substance use and mental health measures.Special topics related to prescription psychotherapeutic drugs.A comparison between NSDUH and other sources of data on substance use and mental health issues, including data sources for populations outside the NSDUH target population.A more in-depth view of special methodological issues for the 2020 NSDUH, including those related to methodological changes made because of the Coronavirus 2019 Pandemic.An appendix covers key definitions used in NSDUH reports and tables.

This report summarizes the 2018 NSDUH methods and other supporting information relevant to estimates of substance use and mental health issues, and organized into five chapters. Chapter 1 is an introduction to the report. Chapter 2 describes the survey, including information about the sample design; data collection procedures; and key aspects of data processing, such as development of analysis weights. Chapter 3 presents technical details on the statistical methods and measurement, such as suppression criteria for unreliable estimates, statistical testing procedures, and issues for selected substance use and mental health measures. Chapter 4 covers special topics related to prescription psychotherapeutic drugs. Chapter 5 describes other sources of data on substance use and mental health issues, including data sources for populations outside the NSDUH target population. Appendix A is a glossary that covers key definitions for use as a resource with the 2018 NSDUH reports and detailed tables. Appendix B provides a list of contributors to the report.

This report is organized into seven sections. Section A describes the survey, including information about the sample design, data collection procedures, and key aspects of data processing (e.g., development of analysis weights). Section B presents technical details on the statistical methods and measurement, such as suppression criteria for unreliable estimates, statistical testing procedures, and issues for selected substance use and mental health measures. Section C discusses special topics related to prescription psychotherapeutic drugs. A glossary that covers key definitions used in NSDUH reports and tables is included in Section D. Section E describes other sources of data on substance use and mental health issues, including data sources for populations outside the NSDUH target population. A list of references cited in the report (Section F) and a list of contributors to this report (Section G) also are provided.

Get detailed national estimates from the 2021 National Survey on Drug Use and Health (NSDUH). The tables provide comprehensive statistics on substance use, mental health, and treatment in the United States. Unlike previous NSDUH detailed tables, there are no trend tables comparing estimates to previous years for 2021. This is because changes in survey methodology mean the indicators are not comparable to past NSDUH estimates.The tables are based on the NSDUH survey, which interviews people ages 12 or older in the civilian, noninstitutionalized population. In the tables, indicators are broken out by a variety of demographic, geographic, and economic variables.The following topics are covered, among others: drug, alcohol, nicotine, and tobacco product use and initiation; substance use disorder (SUD); substance use risk and protective factors; availability of substance use treatment; any mental illness (AMI) and serious mental illness (SMI); major depressive episode (MDE); suicidal thoughts and behaviors; serious psychological distress (SPD); mental health service utilization; treatment for depression; and co-occurrence of mental health issues and SUDs. In 2021, these tables also present the perceived effects of the Coronavirus Disease 2019 (COVID-19) pandemic on substance use and mental health.All of the tables can be downloaded in a zip file which contains both an html and PDF file containing every table. Alternatively, users can open the clickable Table of Contents to go to a particular section. Click on “PE” to get to a population estimate or percentage table, and “SE” to get a standard error table.

The Annual Detailed Tables present in-depth findings on location, characteristics, and utilization of substance use and mental health services as collected by the National Substance Use and Mental Health Survey (N-SUMHSS). The data presented are intended to provide behavioral health services providers; researchers; and federal, state, and local governments with information about the number and characteristics of public and private substance use and mental health treatment facilities nationwide.

The Annual Detailed Tables present in-depth findings on location, characteristics, and utilization of substance use and mental health services as collected by the National Substance Use and Mental Health Survey (N-SUMHSS). The data presented are intended to provide behavioral health services providers; researchers; and federal, state, and local governments with information about the number and characteristics of public and private substance use and mental health treatment facilities nationwide.

Learn about the sample design used for the 2023 National Survey on Drug Use and Health (NSDUH). The report describes the five stages of sample selection, sample weighting and variance estimation procedures, and the Mental Illness Calibration Study sample design.Chapters:Introduces the report, describes the target population, and provides a general overview of the 2023 NSDUH sample design.Summarizes the 2014 through 2023 coordinated sample design.Discusses the first three stages of selection in greater detail.Describes the 2023 NSDUH hybrid field enumeration and address-based sampling frame.Discusses the fourth and fifth stages of selection.Describes sample weighting and variance estimation procedures for 2023.Summarizes the sample design for the Mental Illness Calibration Study.

The Annual Detailed Tables present in-depth findings on location, characteristics, and utilization of substance use and mental health services as collected by the National Substance Use and Mental Health Survey (N-SUMHSS). The data presented are intended to provide behavioral health services providers; researchers; and federal, state, and local governments with information about the number and characteristics of public and private substance use and mental health treatment facilities nationwide.